Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Mol Neurobiol. 2018 Aug 13;56(5):3193–3210. doi: 10.1007/s12035-018-1300-9

Fig. 4.

Fig. 4

Telmisartan significantly reduces LPS-induced IL-β, IL-6, TNFα and Iκβα gene expression. Pretreatment with Telmisartan 10 μM (Telm) for 2 h significantly reduces the increase in a IL-1β gene expression produced after 1 h of exposure to LPS (100 ng/ml). ANOVA F (3, 14) = 37.9 p < 0.0001. b IL-6 gene expression produced after 1 h of exposure to LPS (100 ng/ml). ANOVA F (3, 10) = 52.9 p < 0.0001. c TNFα gene expression produced after 1 h of exposure to LPS (100 ng/ml). ANOVA F (3, 8) = 196.4 p<0.0001. d Iκβα gene expression produced after 1 h of exposure to LPS (100 ng/ml) F (3, 8) = 6.114 p = 0.0182. Results are means ± SEM for three to five groups analyzed independently. Data are expressed as fold-change relative to DMSO and were analyzed by one-way ANOVA followed by Newman-Keuls test for multiple comparisons. ****p < 0.0001, *p < 0.05 compared to DMSO; ####p < 0.0001, ###p < 0.001, #p < 0.05 compared to Telm; ++p < 0.01, +p < 0.05 compared to LPS